CardioMech is a company focused on providing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve. The company develops a medical device to treat high-risk patients suffering from severe symptomatic degenerative mitral regurgitation due to prolapse or flail.
|Employees (est.) (Nov 2019)||7|
CardioMech total Funding
CardioMech latest funding size
Time since last funding
|3 months ago|
When was CardioMech founded?
CardioMech was founded in 2015.
Who are CardioMech key executives?
CardioMech's key executives are Nikolai Hiorth, Rick Nehm and Jacob Bergsland.
How many employees does CardioMech have?
CardioMech has 7 employees.
Who are CardioMech competitors?
Competitors of CardioMech include NeoChord, Avinger and ResMed.
Where are CardioMech offices?
CardioMech has an office in Trondheim.
How many offices does CardioMech have?
CardioMech has 1 office.
Receive alerts for 300+ data fields across thousands of companies